2023
DOI: 10.1001/jamasurg.2022.6337
|View full text |Cite
|
Sign up to set email alerts
|

Cost-effectiveness of Laparoscopic vs Open Gastrectomy for Gastric Cancer

Abstract: ImportanceLaparoscopic gastrectomy is rapidly being adopted worldwide as an alternative to open gastrectomy to treat gastric cancer. However, laparoscopic gastrectomy might be more expensive as a result of longer operating times and more expensive surgical materials. To date, the cost-effectiveness of both procedures has not been prospectively evaluated in a randomized clinical trial.ObjectiveTo evaluate the cost-effectiveness of laparoscopic compared with open gastrectomy.Design, Setting, and ParticipantsIn t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 29 publications
(91 reference statements)
0
8
0
Order By: Relevance
“… Percentages may not add up to 100% due to rounding a Unit prices of D2-gastrectomy in a previous prospective multicenter include the use of operating room, disposable and reusable materials, surgical instruments, and laparoscopic equipment, as reported by Van der Veen et al 8 b The surgical approach (open or laparoscopic) was missing for 36 patients (12%) c The costs of surgical re-interventions were calculated by multiplying the duration of surgery (this could be retrieved for 32% of reoperations) by the €22 minute price of the operating room as previously reported by Bolkenstein et al 20 As 14% of operated patients underwent surgical re-intervention (€2478), the average cost per patient totaled €349 d Surgical re-interventions were recorded until 30 days after surgery …”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“… Percentages may not add up to 100% due to rounding a Unit prices of D2-gastrectomy in a previous prospective multicenter include the use of operating room, disposable and reusable materials, surgical instruments, and laparoscopic equipment, as reported by Van der Veen et al 8 b The surgical approach (open or laparoscopic) was missing for 36 patients (12%) c The costs of surgical re-interventions were calculated by multiplying the duration of surgery (this could be retrieved for 32% of reoperations) by the €22 minute price of the operating room as previously reported by Bolkenstein et al 20 As 14% of operated patients underwent surgical re-intervention (€2478), the average cost per patient totaled €349 d Surgical re-interventions were recorded until 30 days after surgery …”
Section: Resultsmentioning
confidence: 99%
“…a Unit prices of D2-gastrectomy in a previous prospective multicenter include the use of operating room, disposable and reusable materials, surgical instruments, and laparoscopic equipment, as reported by Van der Veen et al 8 …”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In this issue of JAMA Surgery, van der Veen et al publish a detailed cost analysis of the LOGICA trial, comparing quality-adjusted life-years (QALYs) and patient costs up to 1 year postoperatively, and ultimately demonstrate that there is no difference in cost or QALYs between laparoscopic and open approaches. The total cost in the laparoscopic group was 3.0% higher than that in the open group (€26 084 [US $25 965] vs €25 332 [US $25 216]; difference, €752 [US $749]), driven primarily by longer operative times and use of disposable surgical materials with laparoscopy.…”
mentioning
confidence: 99%
“…This study shows that the potential postoperative benefits of minimally invasive gastrectomy match the increased costs of longer operative time and more expensive materials. Laparoscopic gastrectomy continues to emerge as a feasible alternative to open gastrectomy for gastric cancer resection, and van der Veen et al suggest that laparoscopic gastrectomy is on par not only with an open approach regarding oncologic outcomes but also financially.…”
mentioning
confidence: 99%